Decrease in Scavenger Receptor Expression in Human Monocyte-Derived Macrophages Treated with Granulocyte Macrophage Colony-Stimulating Factor

Arteriosclerosis, Thrombosis, and Vascular Biology

Volumn 16, Issue 1, 1996, Pages 106-114

  Van Der Kooij, Maaike A ^a,b   Morand, Olivier H ^a   Kempen, Herman J ^a   Van Berkel, Theo J C ^b  

^a F HOFFMANN LA ROCHE LTD   (Switzerland)

^b LEIDEN UNIVERSITY   (Netherlands)

Author keywords

Atherosclerosis; Cholesterol; Granulocyte macrophage colony stimulating factor; Macrophage; Scavenger receptor

Indexed keywords

GRANULOCYTE MACROPHAGE COLONY STIMULATING FACTOR; LIPOPROTEIN RECEPTOR; LOW DENSITY LIPOPROTEIN; SCAVENGER;

ARTICLE; ATHEROSCLEROSIS; BINDING SITE; CELL DIFFERENTIATION; CHOLESTEROL BLOOD LEVEL; ESTERIFICATION; FOAM CELL; GENE EXPRESSION; HUMAN; HUMAN CELL; LIGAND BINDING; LIPOPROTEIN BLOOD LEVEL; MACROPHAGE FUNCTION; NORTHERN BLOTTING; PRIORITY JOURNAL; PROTEIN DEGRADATION;

BASE SEQUENCE; CELL DIFFERENTIATION; CELL DIVISION; CHOLESTEROL; GENE EXPRESSION; GRANULOCYTE-MACROPHAGE COLONY-STIMULATING FACTOR; HUMANS; IODINE RADIOISOTOPES; LIPOPROTEINS, LDL; MACROPHAGES; MEMBRANE PROTEINS; MOLECULAR SEQUENCE DATA; MONOCYTES; OXIDATION-REDUCTION; RECEPTORS, IMMUNOLOGIC; RECEPTORS, LIPOPROTEIN; RECEPTORS, SCAVENGER; RNA, MESSENGER; SCAVENGER RECEPTORS, CLASS B;

EID: 0030053142     PISSN: 10795642     EISSN: None     Source Type: Journal    
DOI: 10.1161/01.ATV.16.1.106     Document Type: Article

References (57)

1. Brown MS, Goldstein JL. Lipoprotein metabolism in the macrophage: implications for cholesterol deposition in atherosclerosis. Anna Rev Biochem. 1983;52:223-261.
2. Shechter I, Fogelman AM, Haberland ME, Seager J, Hokom M, Edwards PA. The metabolism of native and malondialdehyde altered low density lipoproteins by human monocyte-macrophages. J Lipid Res. 1981;22:63-71.
3. Zhang H, Yang Y, Steinbrecher UP. Structural requirements for the binding of modified proteins to the scavenger receptor of macrophages. J Biol Chem. 1993;268:5535-5542.
4. Phillips DR, Arnold K, Innerarity TL. Platelet secretory products inhibit lipoprotein metabolism in macrophages. Nature. 1985;316:746-748.
5. Hampton RY, Golenbock DT, Penman M, Krieger M, Raetz CR. Recognition and plasma clearance of endotoxin by scavenger receptors. Nature. 1991;353:746-748.
6. Goldstein JL, Ho YK, Basil SK, Brown MS. Binding site on macrophages that mediates uptake and degradation of Ac-LDL producing massive cholesterol deposition. Proc Natl Acad Sci U S A. 1979;76:333-337.
7. Brown MS, Goldstein JL. A receptor-mediated pathway for cholesterol homeostasis. Science. 1986;232:34-47.
8. Schaffner T, Taylor K, Bartucci EJ, Fischer-Dzoga K, Beeson JH, Glagov S, Wissler RW. Arterial foam cells with distinetive immunomorphologic and histochemical features of macrophages. Am J Pathol. 1980;100:57-79.
9. Gerrity RG. The role of the monocyte in atherogenesis, I: transition of blood-borne monocytes into foam cells in fatty lesions. Am J Pathol 1981;103:181-190.
10. Moyer CF, Sajuthi D, Tulli H, Williams JK. Synthesis of IL-1 alpha and IL-beta by arterial cells in atherosclerosis. Am J Pathol. 1991;138:951-960.
11. Rosenfeld ME, Ylä-Herttuala S, Lipton BA, Ord VA, Witztum JL, Steinberg D. M-CSF mRNA and protein in atherosclerotic lesions of rabbits and humans. Am J Pathol. 1992;140:291-300.
12. Ross R, Masuda J, Raines EW, Gown AM, Katsuda S, Sasahara M, Malden T, Masuko H, Sato H. Localization of PDGF-B protein in macrophages in all phases of atherogenesis. Science. 1990;248:1009-1012.
13. Warren MK, Ralph P. Macrophage growth factor CSF-1 stimulates human monocyte production of Interferon, tumor necrosis factor and colony stimulating activity. J Immunol. 1986;137:2281-2285.
14. Filonzi EL, Zoellner H, Stanton H, Hamilton JA, Cytokine regulation of GM-CSF and M-CSF production in human arterial smooth muscle cells. Atherosclerosis. 1993;99:241-252.
15. Hansson GK, Jonasson L, Seifert PS, Stemme S. Immune mechanism in atherosclerosis. Arteriosclerosis. 1989;9:567-578.
16. Motoyoshi K, Suda T, Kusumoto K, Takaku F, Miura Y. Granulocyte-macrophage colony-stimulating and binding activities of purified human urinary colony-stimulating factor to murine and human bone marrow cells. Blood. 1982;60:1378-1386.
17. Motoyoshi K, Takaku F, Mizoguchi H, Miura Y. Purification and some properties of colony-stimulating factor from normal human urine. Blood. 1978;52:1012-1020.
18. Metcalf D, Begley CG, Johnson GR. Biologic properties in vitro of a recombinant human granulocyte macrophage colony-stimulating factor. Blood. 1986;67:37-45.
19. Mufson RA, Aghajanian J, Wong G, Woodhouse C, Morgan AC. Macrophage colony-stimulating factor enhances monocyte and macrophage antibody-dependent cell-mediated cytotoxicity. Cell Immunol. 1989;119:182-192.
20. Grabstein KH, Urdal DL, Tuchinski RJ. Induction of macrophage tumoricidal activity by granulocyte macrophage colony-stimulating factor. Science. 1986;232:506-508.
21. Yamada N, Ishibashi S, Shimano H, Inaba T, Gotoda T, Harada K, Shimada M, Shiomi M, Watanabe Y, Kawakami M, Yazaki Y, Takaku F. Role of macrophage colony-stimulating factor in foam cell generation. Proc Soc Exp Biol Med. 1992;200:240-244.
22. Ishibashi S, Inaba T, Shimano H, Harada K, Inoue I, Mokuno H, Mori N, Gotoda T, Takaku F, Yamada N. Macrophage colonystimulating factor enhances uptake and degradation of Ac-LDL and cholesterol esterification in human monocyte-derived macro-phages. J Biol Chem. 1990;265:14109-14117.
23. Schumaker VN, Puppione DL. Sequential flotation ultracentrifugation. In: Segrest JP, Albers JJ, eds. Methods in Enzymology. London, England: Academic Press; 1986;128:155-170.
24. McFarlane AS. Efficient trace-labelling of proteins with iodine. Nature. 1958;182:53.
25. Bilheimer DW, Eisenberg S, Levy RI. The metabolism of very low density lipoproteins, I: preliminary in vitro and in vivo observations. Biochim Biophys Acta. 1972;260:212-221.
26. Basu SK, Goldstein JL, Anderson RGW, Brown MS. Degradation of cationized low density lipoprotein and regulation of cholesterol metabolism in homozygous familial hypercholesterolemia tibroblasts. Proc Natl Acad Sci U S A. 1976;73:3178-3182.
27. Steinbrecher UP, Witztum JL, Parthasarathy S, Steinberg P. Decrease in reactive amino groups during oxidation or endothelial cell modification of LDL: correlation with changes in receptormediated catabolism. Arteriosclerosis, 1987;7:135-143.
28. Bøyum A. Isolation of mononuclear cells and granulocytes from human blood. Scand J Clin Lab Invest. 1968;21(suppl 96-100):77-89.
29. Bierman EL, Stein O, Stein Y. Lipoprotein uptake and metabolism by rat aortic smooth muscle cells in tissue culture. Circ Res. 1974;35:136-150.
30. Emi M, Asaoka H, Matsumoto A, Itakura H, Kurihara Y, Wada Y, Kanamori H, Yazaki Y, Takahashi E, Lepert M, Lalouel J, Kodama T, Mukau T. Structure, organization and chromosomal mapping of the human macrophage scavenger receptor gene. J Biol Chem. 1993;268:2120-2125.
31. Chomczynski P, Sacchi N. Single-step method of RNA isolation by acid guanidinium thiocyanate-phenol-chloroform extraction. Anal Biochem. 1987;162:156-159.
32. Hara A, Radin NS. Lipid extraction of tissues with a low toxicity solvent. Anal Biochem. 1978;90:420-426.
33. Heider JG, Boyett RL. The picomole determination of free and total cholesterol in cells in culture. J Lipid Res. 1978;19:514-518.
34. Fong LG, Fong AT, Cooper AD. Inhibition of mouse macrophage degradation of Ac-LDL by INF-γ. J Biol Chem. 1990;265:11751-11760.
35. Geng Y, Hansson GK. Interferon-γ inhibits scavenger receptor expression and foam cell formation in human monocyte-derived macrophages. J Clin Invest. 1992;89:1322-1330.
36. Bottalico LA, Wagner RE, Agellon LB, Assoian RK, Tabas I. TGF-β1 inhibits scavenger receptor activity in THP-1 human macrophages. J Biol Chem. 1991;266:22866-22871.
37. Kodama T, Freeman TM, Rohrer L, Zabrecky J, Matsudaira P, Krieger M. Type I macrophage scavenger receptor contains α-helical and collagen-like coiled coils. Nature. 1990;343:531-535.
38. Rohrer L, Freeman M, Kodama T, Penman M, Krieger M. Coiledcoil fibrous domains mediate ligand binding by macrophage scavenger type II. Nature. 1990;343:570-572.
39. Krieger M, Herz J. Structure and functions of multiligand lipoprotein receptors: macrophage scavenger receptors and LDL receptor-related protein (LRP). Annu Rev Biochem. 1994;63:601-637.
40. Naito M, Kodama T, Matsumoto A, Doi T, Takahashi K. Tissue distribution, intracellular localization, and in vivo expression of bovine macrophage scavenger receptors. Am J Pathol. 1991;139:1411-1423.
41. Mori N, Gotoda T, Ishibashi S, Shimano H, Harada K, Inaba T, Takaku F, Yamada N. Effects of human recombinant macrophage colony-stimulating factor on the secretion of lipoprotein lipase from macrophages. Arterioscler Thromb. 1991;11:1315-1321.
42. Shimano H, Yamada N, Motoyoshi K, Matsumoto A, Ishibashi S, Mori N, Takaku F. Plasma cholesterol-lowering activity of monocyte colony-stimulating factor (M-CSF). Ann N Y Acad Sci. 1990;587:362-370.
43. Inaba T, Shimano H, Gotoda T, Harada K, Shimada M, Kawamura M, Yazaki Y, Yamada N. Macrophage colony-stimulating factor regulates both activities of neutral and acidic cholesteryl ester hydrolases in human monocyte-derived macrophages. J Clin Invest. 1993;92:750-757.
44. Kodama T, Reddy P, Kishimoto C, Krieger M. Purification and characterization of a bovine acetyl low density lipoprotein receptor. Proc Natl Acad Sci USA. 1988;85:9238-9242.
45. de Rijke Y, van Berkel ThJC. Liver endothelial and Kupffer cells express different binding proteins for modified low density lipoproteins: Kupffer cells express a 95-kDa membrane protein as a specific binding site for oxidized low density lipoproteins. J Biol Chem. 1994;269:1-4.
46. Arai H, Kita T, Yokode M, Narumiya S, Kawai C. Multiple receptors for modified low-density lipoproteins in mouse peritoneal macrophages: different uptake mechanisms for acetylated and oxidized low-density lipoproteins. Biochem Biophys Res Commun. 1989;150:1375-1382.
47. Sparrow CP, Parthasarathy S, Steinberg D. A macrophage receptor that recognizes oxidized low density lipoprotein but not acetylated low density lipoprotein. J Biol Chem. 1989;264:2599-2604.
48. Aviram M. The contribution of the macrophage receptor for oxidized LDL to its cellular uptake. Biochem Biophys Res Commun. 1991;179:359-365.
49. Ueda Y, Arai H, Kawashima A, Nagano Y, Cho M, Tanaka M, Kita T. Different expression of modified low density lipoprotein receptors in rabbit peritoneal macrophages and Kupffer cells. Atherosclerosis. 1993;101:25-35.
50. Kamps JAAM, Kruijt JK, Kuiper J, van Berkel ThJC. Characterization of the interaction of acetylated LDL and oxidatively modified LDL with human liver parenchymal and Kupffer cells in culture. Arterioscler Thromb. 1992;12:1079-1087.
51. Keidar S, Brook GJ, Rosenblat M, Fuhrman B, Dankner G, Aviram M. Involvement of the macrophage low-density lipoprotein receptor-binding domains in the uptake of oxidized low-density lipoprotein. Arterioscler Thromb. 1992;12:484-493.
52. Lougheed M, Zhang H, Steinbrecher UP. Oxidized low density lipoprotein is resistant to cathepsins and accumulates within macrophages. J Biol Chem. 1991;266:14519-14525.
53. Jessup W, Mander EL, Dean RT. The intracellular storage and turnover of apolipoprotein B of oxidized LDL in macrophages. Biochim Biophys Acta. 1992;1126:167-177.
54. Maor I, Aviram M. Oxidized low density lipoprotein leads to macrophage accumulation of unesterified cholesterol as a result of lysosomal trapping of the lipoprotein hydrolyzed cholesterol ester. J Lipid Res. 1994;35:803-819.
55. Freeman M, Ashkenas J, Rees DJ, Kingsley M, Copeland NG, Jenkins N, Krieger M. An ancient, highly conserved family of cysteine-rich protein domains revealed by cloning type I and type II murine macrophage scavenger receptors. Proc Natl Acad Sci U S A. 1990;87:8810-8814.
56. Geng Y, Kodama T, Hansson GK. Differential expression of scavenger receptor isoforms during monocyte-macrophage differentiation and foam cell formation. Arterioscler Thromb. 1994;14:798-806.
57. van Lenten BJ, Fogelman AM. Lipopolysaccharide-induced inhibition of scavenger receptor expression in human monocyte-macrophages is mediated through tumor necrosis factor-α. J Immunol. 1992;148:112-116.